These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24090705)

  • 21. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-PKU mild hyperphenylalaninemia (MHP)--the dilemma.
    Hanley WB
    Mol Genet Metab; 2011; 104(1-2):23-6. PubMed ID: 21632269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of blood phenylalanine concentrations in children with classical phenylketonuria.
    Hartnett C; Salvarinova-Zivkovic R; Yap-Todos E; Cheng B; Giezen A; Horvath G; Lillquist Y; Vallance H; Stockler-Ipsiroglu S
    Mol Genet Metab; 2013 Apr; 108(4):255-8. PubMed ID: 23465864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.
    Bilder DA; Noel JK; Baker ER; Irish W; Chen Y; Merilainen MJ; Prasad S; Winslow BJ
    Dev Neuropsychol; 2016; 41(4):245-260. PubMed ID: 27805419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
    MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
    Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychiatric symptoms in adults with phenylketonuria.
    Bilder DA; Burton BK; Coon H; Leviton L; Ashworth J; Lundy BD; Vespa H; Bakian AV; Longo N
    Mol Genet Metab; 2013 Mar; 108(3):155-60. PubMed ID: 23339767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased serum ubiquinone-10 concentrations in phenylketonuria.
    Artuch R; Vilaseca MA; Moreno J; Lambruschini N; Cambra FJ; Campistol J
    Am J Clin Nutr; 1999 Nov; 70(5):892-5. PubMed ID: 10539751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
    Sharman R; Sullivan K; Young R; McGill J
    Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum.
    Wibrand F
    Clin Chim Acta; 2004 Sep; 347(1-2):89-96. PubMed ID: 15313145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU).
    Burton BK; Bausell H; Katz R; Laduca H; Sullivan C
    Mol Genet Metab; 2010; 101(2-3):110-4. PubMed ID: 20638313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
    Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
    Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.
    De Silva V; Oldham CD; May SW
    Clin Chem Lab Med; 2010 Sep; 48(9):1271-9. PubMed ID: 20604724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prooxidant-antioxidant balance in patients with phenylketonuria and its correlation to biochemical and hematological parameters.
    Tavana S; Amini S; Hakhamaneshi MS; Andalibi P; Hajir MS; Ardalan A; Abdi M; Fathollahpour A
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):675-80. PubMed ID: 27008692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria.
    Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA
    Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.